Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE AAA Research Reports
LONDON, October 25, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
The U.S. equity market edged higher on Thursday, October 24, 2013. The S&P 500 ended the day at 1,752.07, up 0.33%; the Dow Jones Industrial Average closed at 15,509.21, up 0.62%; and the NASDAQ Composite finished at 3,928.96, up 0.56%. Shares in the healthcare sector finished on a mixed note, even as the broader market posted gains. The major movers in the sector included BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Insmed Inc. (NASDAQ: INSM), Delcath Systems Inc. (NASDAQ: DCTH), and Akorn Inc. (NASDAQ: AKRX). All these companies are tracked by AAAResearchReports.com. Free technical research on BMRN, INSM, DCTH, and AKRX can be downloaded upon signing up at:
Shares in BioMarin Pharmaceutical Inc.'s shares traded between $67.81 and $69.51 on Thursday before ending the day 1.90% higher at $68.96. A total of 1.82 million shares were traded, which is above the daily average volume of 1.52 million. The company's shares have gained 3.40% in the previous three trading sessions and 9.01% in the last 3 months, compared to a gain of 0.42% and 3.92% in the S&P 500 during the respective periods. Moreover, BioMarin Pharmaceutical Inc.'s stock is trading above its 200-day moving average of $62.79. Sign up and read the complimentary report on BMRN at:
Insmed Inc.'s stock plummeted on Thursday, even as the broader market posted gains. The company's shares closed the day at $13.57, down 2.79%, after oscillating between $13.46 and $14.49 during the trading session. A total of 0.54 million shares were traded, which is below the daily average volume of 0.64 million. Despite Thursday's pullback, the company's shares have surged 19.56% in the previous three months, compared to a gain of 3.92% in the S&P 500 during the same period. Furthermore, Insmed Inc.'s stock is trading above its 200-day moving average of $10.33. The free report on INSM can be downloaded by signing up now at:
Delcath Systems Inc.'s shares rose on Thursday, tracking gains in the broader market. The company's shares closed at $0.33, up 2.52%, after oscillating between $0.31 and $0.33 during the trading session. A total of 3.71 million shares were traded, which is above the daily average volume of 2.70 million. The company's shares have gained 9.73% in the previous one month, outperforming the S&P 500, which has gained 3.22% during the same period. However, Delcath Systems Inc.'s stock is trading below its 50-day and 200-day moving averages of $0.38 and $0.86, respectively. A free report on DCTH can be accessed by registering at:
On Thursday, Akorn Inc.'s stock ended the session 1.24% lower than the previous day's price of $20.91. The company's shares oscillated between $20.59 and $20.98 before closing the day at $20.65. A total of 0.61 million shares were traded, which is below the daily average volume of 0.77 million. Despite Thursday's pullback, the company's shares have surged 11.02% in the last one month and 52.29% in the previous three months, outperforming the S&P 500, which has gained 3.22% and 3.92% during the respective periods. Furthermore, Akorn Inc.'s stock is trading near its 52-week high of $21.00 and also above its 50-day and 200-day moving averages of $18.73 and $15.14, respectively. Register with AAA Research Reports and download research on AKRX for free at:
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
©2012 PR Newswire. All Rights Reserved.
PO Box 4508